The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"Cytochrome P450
".
FunFam 4: cytochrome P450 2D15 isoform X1
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 22 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Monooxygenase activity GO:0004497
Catalysis of the incorporation of one atom from molecular oxygen into a compound and the reduction of the other atom of oxygen to water.
|
6 | P10633 (/IDA) P10634 (/IDA) P10635 (/IDA) P10635 (/IDA) P12938 (/IDA) Q64680 (/IDA) |
Monooxygenase activity GO:0004497
Catalysis of the incorporation of one atom from molecular oxygen into a compound and the reduction of the other atom of oxygen to water.
|
3 | Q8CIM7 (/ISO) Q91W87 (/ISO) Q9JKY7 (/ISO) |
Heme binding GO:0020037
Interacting selectively and non-covalently with heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring.
|
3 | Q2XNC8 (/ISS) Q2XNC8 (/ISS) Q2XNC9 (/ISS) |
NADPH-hemoprotein reductase activity GO:0003958
Catalysis of the reaction: NADPH + H+ + n oxidized hemoprotein = NADP+ + n reduced hemoprotein.
|
2 | F7FF10 (/IDA) Q5BKA2 (/IDA) |
Monooxygenase activity GO:0004497
Catalysis of the incorporation of one atom from molecular oxygen into a compound and the reduction of the other atom of oxygen to water.
|
2 | P10634 (/TAS) P12939 (/TAS) |
Drug binding GO:0008144
Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
|
2 | P10635 (/IDA) P10635 (/IDA) |
Arachidonic acid monooxygenase activity GO:0008391
Catalysis of the incorporation of one atom from molecular oxygen into arachidonic acid and the reduction of the other atom of oxygen to water.
|
2 | Q91W87 (/ISO) Q9JKY7 (/ISO) |
Oxidoreductase activity GO:0016491
Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
|
2 | P10635 (/IDA) P10635 (/IDA) |
Heme binding GO:0020037
Interacting selectively and non-covalently with heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring.
|
2 | P10635 (/IDA) P10635 (/IDA) |
NADPH-hemoprotein reductase activity GO:0003958
Catalysis of the reaction: NADPH + H+ + n oxidized hemoprotein = NADP+ + n reduced hemoprotein.
|
1 | O54750 (/ISO) |
Arachidonic acid monooxygenase activity GO:0008391
Catalysis of the incorporation of one atom from molecular oxygen into arachidonic acid and the reduction of the other atom of oxygen to water.
|
1 | Q64680 (/IDA) |
Arachidonic acid epoxygenase activity GO:0008392
Catalysis of an NADPH- and oxygen-dependent reaction that converts arachidonic acid to a cis-epoxyeicosatrienoic acid.
|
1 | P51589 (/IDA) |
Arachidonic acid epoxygenase activity GO:0008392
Catalysis of an NADPH- and oxygen-dependent reaction that converts arachidonic acid to a cis-epoxyeicosatrienoic acid.
|
1 | O54750 (/IMP) |
Arachidonic acid epoxygenase activity GO:0008392
Catalysis of an NADPH- and oxygen-dependent reaction that converts arachidonic acid to a cis-epoxyeicosatrienoic acid.
|
1 | O54750 (/ISO) |
Arachidonic acid 14,15-epoxygenase activity GO:0008404
Catalysis of an NADPH- and oxygen-dependent reaction that converts arachidonic acid to cis-14,15-epoxyeicosatrienoic acid.
|
1 | P51589 (/IDA) |
Arachidonic acid 14,15-epoxygenase activity GO:0008404
Catalysis of an NADPH- and oxygen-dependent reaction that converts arachidonic acid to cis-14,15-epoxyeicosatrienoic acid.
|
1 | O54750 (/ISO) |
Arachidonic acid 11,12-epoxygenase activity GO:0008405
Catalysis of an NADPH- and oxygen-dependent reaction that converts arachidonic acid to cis-11,12-epoxyeicosatrienoic acid.
|
1 | P51589 (/IDA) |
Arachidonic acid 11,12-epoxygenase activity GO:0008405
Catalysis of an NADPH- and oxygen-dependent reaction that converts arachidonic acid to cis-11,12-epoxyeicosatrienoic acid.
|
1 | O54750 (/ISO) |
Isomerase activity GO:0016853
Catalysis of the geometric or structural changes within one molecule. Isomerase is the systematic name for any enzyme of EC class 5.
|
1 | P51589 (/IDA) |
Aromatase activity GO:0070330
Catalysis of the reduction of an aliphatic ring to yield an aromatic ring.
|
1 | A0A087X1C5 (/IDA) |
Linoleic acid epoxygenase activity GO:0071614
Catalysis of an NADPH- and oxygen-dependent reaction that converts linoleic acid to a cis-epoxyoctadecenoic acid.
|
1 | P51589 (/IDA) |
Linoleic acid epoxygenase activity GO:0071614
Catalysis of an NADPH- and oxygen-dependent reaction that converts linoleic acid to a cis-epoxyoctadecenoic acid.
|
1 | O54750 (/ISO) |
There are 58 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Female pregnancy GO:0007565
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
|
4 | F7FF10 (/IEP) P10634 (/IEP) Q5BKA2 (/IEP) Q64680 (/IEP) |
Xenobiotic metabolic process GO:0006805
The chemical reactions and pathways involving a xenobiotic compound, a compound foreign to living organisms. Used of chemical compounds, e.g. a xenobiotic chemical, such as a pesticide.
|
3 | P10635 (/TAS) P10635 (/TAS) P51589 (/TAS) |
Response to organic cyclic compound GO:0014070
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
3 | F7FF10 (/IEP) P10633 (/IEP) Q5BKA2 (/IEP) |
Drug metabolic process GO:0017144
The chemical reactions and pathways involving a drug, a substance used in the diagnosis, treatment or prevention of a disease; as used here antibiotic substances (see antibiotic metabolism) are considered to be drugs, even if not used in medical or veterinary practice.
|
3 | P10635 (/IDA) P10635 (/IDA) Q64680 (/IDA) |
Arachidonic acid metabolic process GO:0019369
The chemical reactions and pathways involving arachidonic acid, a straight chain fatty acid with 20 carbon atoms and four double bonds per molecule. Arachidonic acid is the all-Z-(5,8,11,14)-isomer.
|
3 | F7FF10 (/IDA) Q5BKA2 (/IDA) Q64680 (/IDA) |
Arachidonic acid metabolic process GO:0019369
The chemical reactions and pathways involving arachidonic acid, a straight chain fatty acid with 20 carbon atoms and four double bonds per molecule. Arachidonic acid is the all-Z-(5,8,11,14)-isomer.
|
3 | O54750 (/ISO) Q91W87 (/ISO) Q9JKY7 (/ISO) |
Retinoid metabolic process GO:0001523
The chemical reactions and pathways involving retinoids, any member of a class of isoprenoids that contain or are derived from four prenyl groups linked head-to-tail. Retinoids include retinol and retinal and structurally similar natural derivatives or synthetic compounds, but need not have vitamin A activity.
|
2 | F7FF10 (/IDA) Q5BKA2 (/IDA) |
Regulation of systemic arterial blood pressure by hormone GO:0001990
The process in which hormones modulate the force with which blood passes through the circulatory system. A hormone is one of a group of substances formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells, in the same organism, upon which they have a specific regulatory action.
|
2 | O54749 (/IMP) O54749 (/IMP) |
Angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure GO:0001998
The decrease in blood vessel diameter as a result of the release of angiotensin into the blood stream.
|
2 | O54749 (/IMP) O54749 (/IMP) |
Serotonin biosynthetic process from tryptophan GO:0006587
The chemical reactions and pathways resulting in the formation from tryptophan of serotonin (5-hydroxytryptamine), a monoamine neurotransmitter occurring in the peripheral and central nervous systems, also having hormonal properties.
|
2 | Q91W87 (/ISO) Q9JKY7 (/ISO) |
Steroid metabolic process GO:0008202
The chemical reactions and pathways involving steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus.
|
2 | P10635 (/IMP) P10635 (/IMP) |
C21-steroid hormone metabolic process GO:0008207
The chemical reactions and pathways involving C21-steroid hormones, steroid compounds containing 21 carbons which function as hormones.
|
2 | Q91W87 (/ISO) Q9JKY7 (/ISO) |
Estrogen metabolic process GO:0008210
The chemical reactions and pathways involving estrogens, C18 steroid hormones that can stimulate the development of female sexual characteristics. Also found in plants.
|
2 | P10635 (/IDA) P10635 (/IDA) |
Coumarin metabolic process GO:0009804
The chemical reactions and pathways involving coumarins, compounds derived from the phenylacrylic skeleton of cinnamic acids.
|
2 | P10635 (/IDA) P10635 (/IDA) |
Alkaloid metabolic process GO:0009820
The chemical reactions and pathways involving alkaloids, nitrogen containing natural products which are not otherwise classified as peptides, nonprotein amino acids, amines, cyanogenic glycosides, glucosinolates, cofactors, phytohormones or primary metabolites (such as purine or pyrimidine bases).
|
2 | P10635 (/IDA) P10635 (/IDA) |
Alkaloid catabolic process GO:0009822
The chemical reactions and pathways resulting in the breakdown of alkaloids, nitrogen containing natural products not otherwise classified as peptides, nonprotein amino acids, amines, cyanogenic glycosides, glucosinolates, cofactors, phytohormones or primary metabolites (such as purine or pyrimidine bases).
|
2 | P10635 (/IDA) P10635 (/IDA) |
Response to organic substance GO:0010033
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
|
2 | P10633 (/IEP) Q64680 (/IEP) |
Monoterpenoid metabolic process GO:0016098
The chemical reactions and pathways involving monoterpenoid compounds, terpenoids having a C10 skeleton.
|
2 | P10635 (/IDA) P10635 (/IDA) |
Drug metabolic process GO:0017144
The chemical reactions and pathways involving a drug, a substance used in the diagnosis, treatment or prevention of a disease; as used here antibiotic substances (see antibiotic metabolism) are considered to be drugs, even if not used in medical or veterinary practice.
|
2 | P10635 (/IMP) P10635 (/IMP) |
Drug metabolic process GO:0017144
The chemical reactions and pathways involving a drug, a substance used in the diagnosis, treatment or prevention of a disease; as used here antibiotic substances (see antibiotic metabolism) are considered to be drugs, even if not used in medical or veterinary practice.
|
2 | Q91W87 (/ISO) Q9JKY7 (/ISO) |
Negative regulation of collagen biosynthetic process GO:0032966
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
|
2 | F7FF10 (/IMP) Q5BKA2 (/IMP) |
Isoquinoline alkaloid metabolic process GO:0033076
The chemical reactions and pathways involving isoquinoline alkaloids, alkaloid compounds that contain bicyclic N-containing aromatic rings and are derived from a 3,4-dihydroxytyramine (dopamine) precursor that undergoes a Schiff base addition with aldehydes of different origin.
|
2 | P10635 (/IDA) P10635 (/IDA) |
Negative regulation of peroxisome proliferator activated receptor signaling pathway GO:0035359
Any process that stops, prevents, or reduces the frequency, rate or extent of the peroxisome proliferator activated receptor signaling pathway.
|
2 | F7FF10 (/IMP) Q5BKA2 (/IMP) |
Dopamine biosynthetic process GO:0042416
The chemical reactions and pathways resulting in the formation of dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline.
|
2 | Q91W87 (/ISO) Q9JKY7 (/ISO) |
Dopamine metabolic process GO:0042417
The chemical reactions and pathways involving dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline.
|
2 | Q91W87 (/ISO) Q9JKY7 (/ISO) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
2 | P10633 (/IDA) P10634 (/IDA) |
Retinol metabolic process GO:0042572
The chemical reactions and pathways involving retinol, one of the three compounds that makes up vitamin A.
|
2 | P10635 (/IDA) P10635 (/IDA) |
Drug catabolic process GO:0042737
The chemical reactions and pathways resulting in the breakdown of a drug, a substance used in the diagnosis, treatment or prevention of a disease.
|
2 | P10635 (/IDA) P10635 (/IDA) |
Long-chain fatty acid biosynthetic process GO:0042759
The chemical reactions and pathways resulting in the formation of long-chain fatty acids, any fatty acid with a chain length between C13 and C22.
|
2 | P10635 (/TAS) P10635 (/TAS) |
Heterocycle metabolic process GO:0046483
The chemical reactions and pathways involving heterocyclic compounds, those with a cyclic molecular structure and at least two different atoms in the ring (or rings).
|
2 | P10635 (/IDA) P10635 (/IDA) |
Negative regulation of binding GO:0051100
Any process that stops or reduces the rate or extent of binding, the selective interaction of a molecule with one or more specific sites on another molecule.
|
2 | P10635 (/IDA) P10635 (/IDA) |
Oxidation-reduction process GO:0055114
A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.
|
2 | P10635 (/IDA) P10635 (/IDA) |
Oxidative demethylation GO:0070989
The process of removing one or more methyl groups from a molecule, involving the oxidation (i.e. electron loss) of one or more atoms in the substrate.
|
2 | P10635 (/IDA) P10635 (/IDA) |
Negative regulation of cellular organofluorine metabolic process GO:0090350
Any process that decreases the rate, frequency or extent of the chemical reactions and pathways involving organofluorine compounds, as carried out by individual cells.
|
2 | P10635 (/IDA) P10635 (/IDA) |
Renal tubular secretion GO:0097254
Secretion of substances from peritubular capillaries into the renal tubules to be incorporated subsequently into the urine. Substances that are secreted include organic anions, ammonia, potassium and drugs.
|
2 | O54749 (/IMP) O54749 (/IMP) |
Positive regulation of tumor necrosis factor secretion GO:1904469
Any process that activates or increases the frequency, rate or extent of tumor necrosis factor secretion.
|
2 | F7FF10 (/IMP) Q5BKA2 (/IMP) |
Positive regulation of estrogen secretion GO:2000863
Any process that activates or increases the frequency, rate or extent of estrogen secretion.
|
2 | O54749 (/IMP) O54749 (/IMP) |
Retinoid metabolic process GO:0001523
The chemical reactions and pathways involving retinoids, any member of a class of isoprenoids that contain or are derived from four prenyl groups linked head-to-tail. Retinoids include retinol and retinal and structurally similar natural derivatives or synthetic compounds, but need not have vitamin A activity.
|
1 | O54750 (/ISO) |
Liver development GO:0001889
The process whose specific outcome is the progression of the liver over time, from its formation to the mature structure. The liver is an exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes.
|
1 | P12938 (/IEP) |
Serotonin biosynthetic process from tryptophan GO:0006587
The chemical reactions and pathways resulting in the formation from tryptophan of serotonin (5-hydroxytryptamine), a monoamine neurotransmitter occurring in the peripheral and central nervous systems, also having hormonal properties.
|
1 | Q64680 (/IDA) |
Icosanoid metabolic process GO:0006690
The chemical reactions and pathways involving icosanoids, any of a group of C20 polyunsaturated fatty acids.
|
1 | P51589 (/IDA) |
Icosanoid metabolic process GO:0006690
The chemical reactions and pathways involving icosanoids, any of a group of C20 polyunsaturated fatty acids.
|
1 | P51589 (/TAS) |
Xenobiotic metabolic process GO:0006805
The chemical reactions and pathways involving a xenobiotic compound, a compound foreign to living organisms. Used of chemical compounds, e.g. a xenobiotic chemical, such as a pesticide.
|
1 | A0A087X1C5 (/IDA) |
Regulation of heart contraction GO:0008016
Any process that modulates the frequency, rate or extent of heart contraction. Heart contraction is the process in which the heart decreases in volume in a characteristic way to propel blood through the body.
|
1 | P51589 (/TAS) |
C21-steroid hormone metabolic process GO:0008207
The chemical reactions and pathways involving C21-steroid hormones, steroid compounds containing 21 carbons which function as hormones.
|
1 | Q64680 (/IMP) |
Epoxygenase P450 pathway GO:0019373
The chemical reactions and pathways by which arachidonic acid is converted to other compounds including epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids.
|
1 | P51589 (/IDA) |
Epoxygenase P450 pathway GO:0019373
The chemical reactions and pathways by which arachidonic acid is converted to other compounds including epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids.
|
1 | O54750 (/ISO) |
Epoxygenase P450 pathway GO:0019373
The chemical reactions and pathways by which arachidonic acid is converted to other compounds including epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids.
|
1 | P51589 (/TAS) |
Negative regulation of collagen biosynthetic process GO:0032966
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
|
1 | O54750 (/ISO) |
Negative regulation of peroxisome proliferator activated receptor signaling pathway GO:0035359
Any process that stops, prevents, or reduces the frequency, rate or extent of the peroxisome proliferator activated receptor signaling pathway.
|
1 | O54750 (/ISO) |
Dopamine biosynthetic process GO:0042416
The chemical reactions and pathways resulting in the formation of dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline.
|
1 | Q64680 (/IDA) |
Dopamine metabolic process GO:0042417
The chemical reactions and pathways involving dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline.
|
1 | Q64680 (/IDA) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | Q8CIM7 (/ISO) |
Exogenous drug catabolic process GO:0042738
The chemical reactions and pathways resulting in the breakdown of a drug that has originated externally to the cell or organism.
|
1 | A0A087X1C5 (/IDA) |
Linoleic acid metabolic process GO:0043651
The chemical reactions and pathways involving linoleic acid, an unsaturated omega-6 fatty acid that has the molecular formula C18H32O2.
|
1 | P51589 (/IDA) |
Linoleic acid metabolic process GO:0043651
The chemical reactions and pathways involving linoleic acid, an unsaturated omega-6 fatty acid that has the molecular formula C18H32O2.
|
1 | O54750 (/ISO) |
Oxidative demethylation GO:0070989
The process of removing one or more methyl groups from a molecule, involving the oxidation (i.e. electron loss) of one or more atoms in the substrate.
|
1 | Q9DEW9 (/IMP) |
Positive regulation of tumor necrosis factor secretion GO:1904469
Any process that activates or increases the frequency, rate or extent of tumor necrosis factor secretion.
|
1 | O54750 (/ISO) |
There are 8 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
4 | A0A087X1C5 (/IDA) P10633 (/IDA) Q91W87 (/IDA) Q9JKY7 (/IDA) |
Intracellular membrane-bounded organelle GO:0043231
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
|
4 | F7FF10 (/IDA) P10634 (/IDA) Q5BKA2 (/IDA) Q64680 (/IDA) |
Intracellular membrane-bounded organelle GO:0043231
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
|
4 | O54750 (/ISO) Q8CIM7 (/ISO) Q91W87 (/ISO) Q9JKY7 (/ISO) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
3 | A0A087X1C5 (/IDA) P10635 (/IDA) P10635 (/IDA) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
3 | O54750 (/IDA) Q924D1 (/IDA) Q9CRQ9 (/IDA) |
Endoplasmic reticulum membrane GO:0005789
The lipid bilayer surrounding the endoplasmic reticulum.
|
3 | P10635 (/TAS) P10635 (/TAS) P51589 (/TAS) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
2 | P10635 (/TAS) P10635 (/TAS) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
1 | P51589 (/HDA) |